Immunology and autoimmune
Everything filed under areas in our medical research coverage, the 6 reports filed on it so far.
Flagship Pioneering launches AI drug discovery company Etcelera
Flagship Pioneering merged three AI biotech startups into a new company, Etcelera, on October 29, 2026. The firm, led by Adrian Rawcliffe, combines...
Regeneron and Sanofi Expand Antibody Alliance in $8 Billion Deal
Regeneron and Sanofi have expanded their long-standing collaboration with an $8 billion deal to co-develop four next-generation immunology drugs.
Novartis, Bristol Myers pause autoimmune CAR-T trials
Novartis and Bristol Myers Squibb have paused multiple trials of their CAR-T therapies for autoimmune diseases following serious safety incidents.
Novartis, BMS Pause CAR-T Autoimmune Trials
Novartis and Bristol Myers Squibb have paused clinical trials of their CAR T-cell therapies for autoimmune diseases following severe adverse events.
Novartis, BMS halt autoimmune CAR-T trials
Novartis paused CD19 CAR-T trials after three patient deaths, and Bristol Myers Squibb halted enrollment in a similar program due to inflammatory...
AstraZeneca, Amgen's Tezspire succeeds in Phase 3 eosinophilic esophagitis trial
AstraZeneca and Amgen's Tezspire succeeded in a Phase 3 trial for eosinophilic esophagitis, potentially expanding the label for the immunology drug.